Abstract

BioMAP® Phenotypic Screening and Profiling supports discovery and development of safe and effective medicines for patients. BioMAP Diversity Early Screening service allows clients to screen more compounds, more quickly, than our flagship BioMAP Diversity PLUS® profiling option. A new interactive data report for BioMAP Diversity Early Screening, built in Tableau, helps scientists more easily understand and apply their data for decision-making. A video presentation by Chief Scientific Officer Ellen Berg provides an overview of the different data dashboards available by walking viewers through an example client report